Pharmaceutical and health biotechnologies
From cancer to emerging infections, biotech is redefining how we prevent, diagnose, and treat disease.
- Antibodies and therapeutic proteins
- Gene and cellular therapies
- Medical technologies
- Medicinal chemistry
- Molecular modelling and recognition
- Natural products
- Regenerative medicine
- Small molecule drug discovery and development
- Tissue engineering
Director, Cell Therapy and Cell Engineering Facility
Memorial Sloan Kettering Cancer Centre
Isabelle Rivière biography
Dr. Rivière received her Ph.D. in Cellular and Molecular Biology from the University of Paris. She initiated her graduate studies at the Institut Curie in Paris and completed her thesis in the laboratory of Dr. Mulligan at the Whitehead Institute in Cambridge, MA. During this time, she developed novel retroviral vectors for in vivo long-term expression of transgenes in hematopoietic cells using MFG/SFG-based retroviral vectors that are widely used in clinical studies for the treatment of genetic and acquired disorders.
She subsequently worked as a post-doctoral fellow in the laboratory of Dr. Littman at New York University, NY. Dr. Rivière joined the faculty of Memorial Sloan-Kettering Cancer Center in 1999. She is currently the Director of the Michael G. Harris Cell Therapy and Cell Engineering Facility where she investigates the genetic modification of hematopoietic cells to increase or retarget the immune response against tumors.
- Date modified: